Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias R Lemke

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Psychiatry|May 10, 2002
Effect of reboxetine on depression in Parkinson's disease patientsMatthias R Lemke
Journal of the Neurological Sciences|July 4, 2006
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's diseaseMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 9, 2005
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexoleMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
Psychiatrische Praxis|April 28, 2020
[COVID-19 Pandemic: Stress Experience of Healthcare Workers - A Short Current Review]Jens Bohlken, Friederike Schömig, Matthias R Lemke, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Modulation of involuntary and voluntary behavior following emotional stimuli in healthy subjectsMatthias R Lemke, Christian J Fischer, Thomas Wendorff, et al.
Journal of Neurology|January 29, 2005
Depression and Parkinson's diseaseMatthias R Lemke, Gerd Fuchs, Irene Gemende, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristicsDaniel J Müller, Katrin Barkow, Svetlana Kovalenko, et al.
The Journal of Sexual Medicine|May 10, 2008
Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidoneJens Westheide, Gabriele Cvetanovska, Carsten Albrecht, et al.
Psychopathology|July 17, 2012
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating ScaleRebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
The Psychiatric Quarterly|November 1, 2011
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Psychiatry|May 10, 2002
Effect of reboxetine on depression in Parkinson's disease patientsMatthias R Lemke
Journal of the Neurological Sciences|July 4, 2006
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's diseaseMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 9, 2005
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexoleMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
Psychiatrische Praxis|April 28, 2020
[COVID-19 Pandemic: Stress Experience of Healthcare Workers - A Short Current Review]Jens Bohlken, Friederike Schömig, Matthias R Lemke, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Modulation of involuntary and voluntary behavior following emotional stimuli in healthy subjectsMatthias R Lemke, Christian J Fischer, Thomas Wendorff, et al.
Journal of Neurology|January 29, 2005
Depression and Parkinson's diseaseMatthias R Lemke, Gerd Fuchs, Irene Gemende, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristicsDaniel J Müller, Katrin Barkow, Svetlana Kovalenko, et al.
The Journal of Sexual Medicine|May 10, 2008
Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidoneJens Westheide, Gabriele Cvetanovska, Carsten Albrecht, et al.
Psychopathology|July 17, 2012
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating ScaleRebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
The Psychiatric Quarterly|November 1, 2011
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Pageof 3